PMN - ProMIS Neurosciences Inc.


24.6
1.810   7.358%

Share volume: 45,581
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%

$22.79
1.81
0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
38%
Profitability 35%
Dept financing 34%
Liquidity 50%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
4.64%
1 Month
57.19%
3 Months
222.41%
6 Months
5,620.93%
1 Year
3,057.89%
2 Year
3,094.81%
Key data
Stock price
$24.60
P/E Ratio 
0.00
DAY RANGE
$21.63 - $25.00
EPS 
-$0.74
52 WEEK RANGE
$0.29 - $25.00
52 WEEK CHANGE
$3,061.95
MARKET CAP 
22.018 M
YIELD 
N/A
SHARES OUTSTANDING 
53.811 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$72,985
AVERAGE 30 VOLUME 
$69,072
Company detail
CEO: Gail M. Farfel
Region: US
Website: promisneurosciences.com
Employees: 5
IPO year: 2008
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

N/A

Recent news